Propofol Market Size

  • Report ID: 3132
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Propofol Market Size

Propofol Market size was over USD 989.4 million in 2023 and is poised to cross USD 1.91 billion by 2036, growing at more than 5.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of propofol is evaluated at USD 1.03 billion. As the number of medical procedures performed such as general surgical, orthodontic and dental surgical procedures, and cataract removal surgeries is increasing, the demand for propofol drug across the world is also projected to rise in the upcoming years. On an average, approximately 235 million surgeries are performed worldwide. According to the World Health organization (WHO), 58.9% of these surgeries occur in high-income countries. Along with this, growing requirement for minimally invasive surgery procedures globally is also expected to drive market growth in the coming years. Furthermore, research and development activities initiated by the top market players for commercialization as well as new product development is anticipated to offer ample growth opportunities to the market in the near future.


Propofol-Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3132
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of propofol is evaluated at USD 1.03 billion.

Propofol Market size was over USD 989.4 million in 2023 and is poised to cross USD 1.91 billion by 2036, growing at more than 5.2% CAGR during the forecast period i.e., between 2024-2036. High influence of propofol on the anesthesia practice and rise in the number of surgical procedures will propel the market growth.

North America is poised to account for largest revenue share by 2036, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.

The major players in the market are Pfizer Inc., Bachem Holding AG, Porton Fine Chemicals Ltd., SI Group, Inc., AstraZeneca plc, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample